Results 271 to 280 of about 9,113,589 (351)

Upper gastrointestinal Crohn's disease: What are we talking about? [PDF]

United European Gastroenterol J
Bertin L, Barberio B, Savarino EV.
europepmc   +1 more source

Antibodies to viral gastroenteritis viruses in Crohn's disease

, 1979
Harry B. Greenberg, R L Gebhard, Craig J. McClain, R. D. Soltis, Albert Z. Kapikian   +4 more
openalex   +1 more source

Serum Collagen Biomarkers Are Reflective of Tissue Specific Fibroblasts Associated With Ulcerative Colitis Activity and Treatment Response to Ustekinumab

United European Gastroenterology Journal, EarlyView.
ABSTRACT Background There is a need to identify peripheral biomarkers reflective of defined disease associated fibroblasts in Ulcerative Colitis (UC), with the aim of enabling clinical development approaches for novel‐stromal‐targeted therapeutics for individuals at risk for fibrostenotic complications.
Swati Venkat, Joshua Rusbuldt, Dylan Richards, Thomas Freeman, Camilla Richmond, Joachim Hog Mortensen, Jakob Benedict Seidelin, Anja Poulsen, Brad McRae, Darren Ruane   +9 more
wiley   +1 more source

A Rare Presentation of a Devastating Disease: Hepatosplenic T-Cell Lymphoma in Crohn's Disease Without Thiopurine Exposure. [PDF]

ACG Case Rep J
Chang M, Frohlinger M, Williams N, George L.   +3 more
europepmc   +1 more source

Endoscopic Techniques for Colorectal Neoplasia Surveillance in Inflammatory Bowel Disease: A Systematic Review and Network Meta‐Analysis

United European Gastroenterology Journal, EarlyView.
ABSTRACT Background and Aims Dye‐based chromoendoscopy (DCE) has been the preferred method for colonoscopy surveillance in patients with inflammatory bowel disease (IBD). However, with advances in endoscopy, virtual chromoendoscopy (VCE) techniques have emerged.
Chih‐Wen Huang, Hsu‐Heng Yen, Yang‐Yuan Chen   +2 more
wiley   +1 more source

De Novo Crohn's Disease 3 Years Following Immune Checkpoint Inhibitor Therapy. [PDF]

ACG Case Rep J
Bell MG, Braga Neto MB, Kane SV.
europepmc   +1 more source

Pancreatic Enzyme Replacement Therapy Improves Exclusive Enteral Nutrition Related Diarrhea in Crohn's Disease: A Prospective Randomized Trial

United European Gastroenterology Journal, EarlyView.
ABSTRACT Background & Aims Previous results showed that combined treatment of biologics and exclusive enteral nutrition (EEN) brought moderate‐to‐severe Crohn's disease patients significant improvements in clinical and endoscopic outcomes. Despite its essential role and favorable safety profile, EEN in the treatment of adult Crohn's disease is ...
Jian Kang, Jing Wang, Juan Su, Wei Wang, Yueyue Lu, Zhishun Tang, Liping Zou, Anning Yin, Jiao Li, Haixia Ren, Qian Zhou, Huipeng Wan, Ping An   +12 more
wiley   +1 more source

Establishment of a surveillance program for anal cancer in Crohn's disease. [PDF]

World J Gastroenterol
Kayano H, Okada KI, Yamamoto S, Koyanagi K.   +3 more
europepmc   +1 more source

Faecalibacterium Diversity in the Gut Microbiome of Crohn's Disease Patients

United European Gastroenterology Journal, EarlyView.
ABSTRACT Faecalibacterium has recently garnered attention for its potential health implications. To better understand its role, we developed and assessed real‐time PCR assays for detecting and quantifying various Faecalibacterium species in human stool samples from both healthy individuals and Crohn's disease patients, either in flare or remission. The
Paul Mclellan, Sandrine Auger, Marie Therese Goudiaby, Loic Brot, Nicolas Benech, Jean Pierre Grill, Anne Bourrier, Denis Mariat, Camille Mayeur, Muriel Thomas, Véronique Robert, Julien Kirchgesner, Laurent Beaugerie, Harry Sokol, Philippe Langella, Philippe Seksik, Jean Marc Chatel   +16 more
wiley   +1 more source